Publications in collaboration with researchers from Hospital Universitario de Cruces (31)

2026

  1. Involvement of autoantibodies against G protein-coupled receptors in post-COVID condition and Chronic Fatigue Syndrome

    Scientific Reports, Vol. 16, Núm. 1

  2. Two-timepoint multidomain follow-up of post-COVID condition and ME/CFS: overlapping autonomic, small-fiber, and cognitive changes

    Journal of Translational Medicine, Vol. 24, Núm. 1

2025

  1. Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s disease

    Scientific Reports, Vol. 15, Núm. 1

  2. Deep Brain Stimulation for Status Dyskineticus in ADCY5-Related Dyskinesia in a 60-Year-Old Woman

    Movement Disorders Clinical Practice, Vol. 12, Núm. 11, pp. 1987-1991

  3. Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

    PLoS ONE, Vol. 20, Núm. 3 March

  4. Effect of sex on the progression of non-motor symptoms in Parkinson's disease: A registry-based cohort study

    Neurologia, Vol. 40, Núm. 7, pp. 620-629

  5. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology, Vol. 32, Núm. 1

  6. Evaluating prognostic factors for falls in Parkinson's disease: A sex-based analysis

    Clinical Neurology and Neurosurgery, Vol. 249

  7. Huntington’s Disease, Cognition, and Biological Markers

    Handbook of the Behavior and Psychology of Disease (Springer Science+Business Media), pp. 1267-1292

  8. Pearls & Oy-sters: ADCY5-Related Dyskinesia: From a Longstanding Misdiagnosis of Drug-Resistant Epilepsy

    Neurology, Vol. 104, Núm. 10, pp. e213661

  9. Progression of visual cognition and neuropsychiatric symptoms in Huntington’s disease: a 1-year follow-up study across preclinical and clinical phases

    Frontiers in Psychology, Vol. 16

  10. Small fiber neuropathy in the post-COVID condition and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical significance and diagnostic challenges

    European Journal of Neurology, Vol. 32, Núm. 2

2024

  1. Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson’s disease: a systematic review

    Frontiers in Nutrition, Vol. 11

  2. Plasma Neurofilament Light Chain: A Potential Biomarker for Neurological Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Biomedicines, Vol. 12, Núm. 7

  3. Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations

    Frontiers in Psychology, Vol. 15

  4. Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson’s Disease

    Brain Sciences, Vol. 14, Núm. 12

2023

  1. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  2. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829

  3. Usefulness of thermography in the diagnosis and classification of complex regional pain syndrome

    Neurologia, Vol. 38, Núm. 5, pp. 342-349

2022

  1. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

    Journal of Translational Medicine, Vol. 20, Núm. 1